Table 5.
Gene mutations in CTCs from cancer patients.
Sample number | Diagnosis | Stage | Pathological mutation | CTC counts (/4mL) | Tested mutation in CTCs | Result |
---|---|---|---|---|---|---|
1 | NSCLC | IV | EGFR 19del | 11 | EGFR 19del | Positive |
2 | NSCLC | IV | EGFR 19del | 40 | EGFR 19del | Positive |
3 | NSCLC | IV | EGFR 19del | 7 | EGFR 19del | Positive |
4 | NSCLC | III | EGFR 19del | 3 | EGFR 19del | Positive |
5 | NSCLC | IV | EGFR 19del | 14 | EGFR 19del | Positive |
6 | PAAD | IV | KRAS G12D | 3 | KRAS G12D | Negative |
7 | PAAD | IV | KRAS G12D | 5 | KRAS G12D | Positive |
8 | PAAD | III | KRAS G12D | 25 | KRAS G12D | Positive |
9 | PAAD | IV | KRAS G12D | 6 | KRAS G12D | Positive |
10 | PAAD | IV | KRAS G12D | 10 | KRAS G12D | Positive |
11 | CRC | IV | BRAF V600E | 8 | BRAF V600E | Positive |
12 | CRC | III | BRAF V600E | 5 | BRAF V600E | Positive |
13 | CRC | IV | BRAF V600E | 10 | BRAF V600E | Positive |
14 | CRC | IV | BRAF V600E | 11 | BRAF V600E | Positive |
15 | CRC | IV | BRAF V600E | 6 | BRAF V600E | Positive |